Retrospective analysis of treatement modalities and treament outcome in patients with aggressive b-cell lymphoma at Freiburg University CCCF Lymphomacenter

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028289

Enrollment

160

Registered

2022-02-25

Start date

2022-02-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C83.3

Interventions

Group 1: Retrospective analysis of all patients with aggressive B-cell lymphoma according to treatement modalities and outcome presented at Freiburg University Medical Center from 2005 to 2022. Group

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age 18 or older, diagnosis of aggressive B-cell lymphoma, first diagnosis or first line therapy at freiburg university medical center

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

Measure	Time frame
Overall response rate, complete-remission rate, progression-free survival	—

Secondary

Measure	Time frame
Overall survival	—

Countries

Germany

Contacts

Public ContactReinhard Marks

Medizinische Klinik I - LymphomzentrumUniversitätsklinikum Freiburg

reinhard.marks@uniklinik-freiburg.de0761/270-36190

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026